×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AGEN – agenus inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AGEN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/7
07:48 am
agen
Agenus (AGEN) was upgraded by Zacks Research from "hold" to "strong-buy".
Medium
Report
Agenus (AGEN) was upgraded by Zacks Research from "hold" to "strong-buy".
4/6
01:06 am
agen
Agenus (AGEN) was upgraded by Wall Street Zen from "hold" to "buy".
High
Report
Agenus (AGEN) was upgraded by Wall Street Zen from "hold" to "buy".
4/3
08:02 pm
agen
Has Agenus (AGEN) Outpaced Other Medical Stocks This Year? [Yahoo! Finance]
High
Report
Has Agenus (AGEN) Outpaced Other Medical Stocks This Year? [Yahoo! Finance]
4/3
01:39 pm
agen
All You Need to Know About Agenus (AGEN) Rating Upgrade to Strong Buy [Yahoo! Finance]
High
Report
All You Need to Know About Agenus (AGEN) Rating Upgrade to Strong Buy [Yahoo! Finance]
4/3
07:30 am
agen
Agenus Announces Data from Phase II Study of BOT+BAL in Combination with agent-797 in PD-1 Refractory Gastroesophageal Cancer to be Presented at AACR 2026
High
Report
Agenus Announces Data from Phase II Study of BOT+BAL in Combination with agent-797 in PD-1 Refractory Gastroesophageal Cancer to be Presented at AACR 2026
4/1
08:24 am
agen
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer [Yahoo! Finance]
Low
Report
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer [Yahoo! Finance]
4/1
07:30 am
agen
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer
Low
Report
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer
4/1
02:04 am
agen
Agenus Inc. (AGEN) Shareholder/Analyst Call Transcript [Seeking Alpha]
Low
Report
Agenus Inc. (AGEN) Shareholder/Analyst Call Transcript [Seeking Alpha]
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/6
04:15 pm
agen
Form 4 AGENUS INC For: Apr 03 Filed by: ARMEN GARO H
Medium
Report
Form 4 AGENUS INC For: Apr 03 Filed by: ARMEN GARO H
4/2
04:31 pm
agen
Form 4 AGENUS INC For: Apr 01 Filed by: Wright Timothy
High
Report
Form 4 AGENUS INC For: Apr 01 Filed by: Wright Timothy
3/26
03:12 pm
agen
Form SCHEDULE 13G/A AGENUS INC Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A AGENUS INC Filed by: VANGUARD GROUP INC
3/26
08:25 am
agen
Form 8-K AGENUS INC For: Mar 24
Medium
Report
Form 8-K AGENUS INC For: Mar 24
3/24
04:15 pm
agen
Form 4 AGENUS INC For: Mar 20 Filed by: ARMEN GARO H
Neutral
Report
Form 4 AGENUS INC For: Mar 20 Filed by: ARMEN GARO H
3/16
05:19 pm
agen
Form 10-K AGENUS INC For: Dec 31
High
Report
Form 10-K AGENUS INC For: Dec 31
3/16
08:15 am
agen
Form 8-K AGENUS INC For: Mar 16
Medium
Report
Form 8-K AGENUS INC For: Mar 16
3/9
04:15 pm
agen
Form 4 AGENUS INC For: Mar 06 Filed by: ARMEN GARO H
Medium
Report
Form 4 AGENUS INC For: Mar 06 Filed by: ARMEN GARO H
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/8
Form 8-K AGENUS INC For: Aug 08
17.6%
3/10 First QS-21 Royalty Payment Due to Agenus is Triggered 16.6%
11/5 Agenus Inc. 2019 Q3 - Results - Earnings Call Presentation [Seeking Alpha] 13.3%
3/24 Agenus Inc (NASDAQ: AGEN) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $2.25 price target on the stock. 11.5%
11/11 Agenus Inc (NASDAQ: AGEN) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 9.2%
5/9 Q1/2019 3/31/2019 EPS 0.120 ZacksConsensus -0.300 ActVsEst 0.420 - Beat 8.7%
11/4 Form 8-K AGENUS INC For: Nov 04 7.7%
11/4 Agenus Inc. (AGEN) CEO Dr. Garo Armen on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 5.6%
10/31 Agenus to Report Third Quarter 2019 Financial Results on November 4, 2019 and Host Conference Call and Webcast 5.1%
8/6 Agenus to Report Second Quarter 2019 Financial Results on August 8, 2019 and Host Conference Call and Webcast 4.9%
3/10 First QS-21 Royalty Payment Due to Agenus is Triggered 16.6%
11/5 Agenus Inc. 2019 Q3 - Results - Earnings Call Presentation [Seeking Alpha] 13.3%
3/24 Agenus Inc (NASDAQ: AGEN) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $2.25 price target on the stock. 11.5%
11/11 Agenus Inc (NASDAQ: AGEN) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 9.2%
5/9 Q1/2019 3/31/2019 EPS 0.120 ZacksConsensus -0.300 ActVsEst 0.420 - Beat 8.7%
11/4 Form 8-K AGENUS INC For: Nov 04 7.7%
11/4 Agenus Inc. (AGEN) CEO Dr. Garo Armen on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 5.6%
10/31 Agenus to Report Third Quarter 2019 Financial Results on November 4, 2019 and Host Conference Call and Webcast 5.1%
8/6 Agenus to Report Second Quarter 2019 Financial Results on August 8, 2019 and Host Conference Call and Webcast 4.9%
TOP News Decliners
2/19
Agenus Stock Rises Ahead of Investor Day Presentation [The Motley Fool]
-15.0%
2/24 Form 8-K AGENUS INC For: Feb 18 -11.3%
3/12 Form 8-K AGENUS INC For: Mar 12 -10.0%
8/2 Form 8-K AGENUS INC For: Jul 30 -8.1%
12/6 Edited Transcript of AGEN earnings conference call or presentation 4-Nov-19 1:30pm GMT [Yahoo! Finance News] -8.0%
3/16 Form 10-K AGENUS INC For: Dec 31 -7.7%
2/20 Here's Why Agenus Tumbled Today [The Motley Fool] -7.6%
3/16 Agenus Inc. Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates [Yahoo! Finance News] -7.1%
3/3 Agenus to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020 with Conference Call and Webcast -5.7%
5/30 MiMedx Announces Comprehensive Board Refreshment Plan in Cooperation with Prescience Point -5.4%
2/24 Form 8-K AGENUS INC For: Feb 18 -11.3%
3/12 Form 8-K AGENUS INC For: Mar 12 -10.0%
8/2 Form 8-K AGENUS INC For: Jul 30 -8.1%
12/6 Edited Transcript of AGEN earnings conference call or presentation 4-Nov-19 1:30pm GMT [Yahoo! Finance News] -8.0%
3/16 Form 10-K AGENUS INC For: Dec 31 -7.7%
2/20 Here's Why Agenus Tumbled Today [The Motley Fool] -7.6%
3/16 Agenus Inc. Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates [Yahoo! Finance News] -7.1%
3/3 Agenus to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020 with Conference Call and Webcast -5.7%
5/30 MiMedx Announces Comprehensive Board Refreshment Plan in Cooperation with Prescience Point -5.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: